Home › NDC Lookup › RxCUI directory › RxCUI 2717843

Probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet — RxCUI 2717843

Name: Probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet (RxCUI 2717843)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2717843 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2717843

Official nameProbenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Probenecid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Probenecid works differently from anti-inflammatory gout drugs like colchicine. Instead of just calming a flare, it actually helps your kidneys flush out more uric acid — the subst...
Why did my doctor prescribe probenecid for my gout? I thought gout was treated with other drugs.
Aspirin is one you really need to avoid with probenecid — even a small dose of aspirin blocks probenecid from doing its job of lowering uric acid. Ibuprofen and similar NSAIDs are...
Can I take aspirin or ibuprofen for pain while I'm on probenecid?

📖 Read our full Probenecid guide →

🕸️ Concept Web — How Probenecid 500 MG / sulopenem etzadroxil 500 MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet RxCUI 2717843 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Probenecid 8698 IN
- Sulopenem 2717833 IN
- Probenecid / sulopenem 2717836 MIN
- Sulopenem etzadroxil 2717834 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Orlynvah 2717844 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Probenecid / sulopenem Oral Tablet 2717839 SCDF
- Probenecid / sulopenem etzadroxil Oral Tablet 2717842 SCDFP
- Probenecid / sulopenem Oral Product 2717837 SCDG
- Probenecid / sulopenem Pill 2717838 SCDG
- Probenecid / sulopenem etzadroxil Oral Product 2717840 SCDGP
- Probenecid / sulopenem etzadroxil Pill 2717841 SCDGP
- Probenecid / sulopenem Oral Tablet [Orlynvah] 2717848 SBDF
- Probenecid / sulopenem etzadroxil Oral Tablet [Orlynvah] 2717849 SBDFP
- +5 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Probenecid 500 MG 316591 SCDC
- Sulopenem etzadroxil 500 MG 2717835 SCDC
- Probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] 2717850 SBD
- Probenecid 500 MG / sulopenem etzadroxil 500 MG [Orlynvah] 2717845 SBDC

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Probenecid 500 MG SCDC · 316591
Sulopenem etzadroxil 500 MG SCDC · 2717835
Probenecid / sulopenem Oral Tablet SCDF · 2717839
Probenecid / sulopenem etzadroxil Oral Tablet SCDFP · 2717842
Probenecid / sulopenem Oral Product SCDG · 2717837
Probenecid / sulopenem Pill SCDG · 2717838
Probenecid / sulopenem etzadroxil Oral Product SCDGP · 2717840
Probenecid / sulopenem etzadroxil Pill SCDGP · 2717841

Brand-Name Concepts

Probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] SBD · 2717850
Probenecid 500 MG / sulopenem etzadroxil 500 MG [Orlynvah] SBDC · 2717845
Probenecid / sulopenem Oral Tablet [Orlynvah] SBDF · 2717848
Probenecid / sulopenem etzadroxil Oral Tablet [Orlynvah] SBDFP · 2717849
Orlynvah Oral Product SBDG · 2717846
Orlynvah Pill SBDG · 2717847
Orlynvah BN · 2717844

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2717843 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
81153-0100-01	1 BOTTLE in 1 CARTON (81153-100-01) / 10 TABLET, FILM COATE...	ORLYNVAH	ITERUM THERAPEUTICS US LIMITED	2025-07-01

Observed labelers: ITERUM THERAPEUTICS US LIMITED (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.